Requirement of the CD8 + or CD4 + T lymphocyte subsets for the rejection of lymphoma and fibrosarcoma grafts studied in gene knockout hosts

Immunology Letters

Volumn 61, Issue 2-3, 1998, Pages 187-190

  Wen, Tao ^a,b   Trümper, Lorenz ^a   Fung Leung, Waiping ^a   Rahemtulla, Amin ^a   Klein, Eva ^b   Klein, George ^b   Mak, Tak W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

CD4; CD8; Knockout mice; Tumor rejection

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; CANCER TRANSPLANTATION; CELLULAR IMMUNODEFICIENCY; FIBROSARCOMA; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOREGULATION; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CARCINOGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL TRANSPLANTATION; FEMALE; FIBROSARCOMA; GRAFT REJECTION; LYMPHOMA, T-CELL; MALE; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RAUSCHER VIRUS;

EID: 0032052765     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2478(98)00022-4     Document Type: Article

References (17)

1. Klein G., Sjögren H.O., Klein E., Hellstrom K.E. Cancer Res. 20:1960;1561-1572.
2. Prehn R.T., Main J.M. J. Natl. Cancer Inst. 18:1957;835-837.
3. Sjögren H.O., Hellstrom I., Klein G. Exp. Cell Res. 23:1961;204-208.
4. Boon T., Cerrottini J., van den Eynde B., van der Bruggen B., van Pel A. Annu. Rev. Immunol. 12:1994;337-365.
5. Chou T., Shu S. J. Immunol. 139:1987;2103-2109.
6. Greenberg P.D. Adv. Immunol. 49:1991;281-355.
7. Klarnet J.P., Kern D.E., Okuno K., Holt C., Lilly F., Greenberg P.D. J. Exp. Med. 169:1989;457-467.
8. Melief C.J.M. Adv. Cancer Res. 58:1992;143-175.
9. Ljunggren G., Ljunggren H., Dalianis T. Virology. 198:1994;714-716.
10. Robins R.A., Baldwin R.W. Immunol. Today. 6:1985;55-58.
11. Udono H., Levey D.L., Srivastava P.K. Proc. Natl. Acad. Sci. USA. 91:1993;3077-3081.
12. Pfeffer K., Mak T.W. Annu. Rev. Immunol. 14:1994;367-411.
13. Fung-Leung W.P., Shilham M.W., Rahemtulla A., Kundig T.M., Vollenweider M., Potter J., van Ewijk W., Mak T.W. Cell. 65:1991;443-449.
14. Rahemtulla A., Fung-Leung W.P., Shilham M.W., Kundig T.M., Sambhara S.R., Narendran A., Arabian A., Wakeham A., Paige C.J., Zinkernagel R.M., Miller R.G., Mak T.W. Nature. 353:1991;180-184.
15. Schilham M.W., Fung-Leung W.P., Rahemtulla A., Kuendig T., Zhang L., Potter J., Miller R.G., Hengartner H., Mak T.W. Eur. J. Immunol. 23:1993;1299-1304.
16. Haran-Ghera N., Ben-Yaakov M., Peled A. J. Immunol. 118:1977;600-606.
17. Kono K., Petersson M., Ciupitu A.M., Wen T., Klein G., Kiessling R. Cancer Res. 55:1995;5648-5655.